REGENXBIO Inc. (RGNX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About REGENXBIO Inc.
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform.…
Source: Yahoo Finance
Sector & Industry
REGENXBIO Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
REGENXBIO Inc. at a Glance
| Company | REGENXBIO Inc. |
| Ticker | RGNX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $8.94 |
| Market cap | $590.16M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.78 |
| 52-week high | $16.19 |
| 52-week low | $5.46 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.93 |
| Return on equity (ROE) | -137.63% |
| Debt-to-equity | 349.00% |
| Average volume | 1.95M |
| Shares outstanding | 66.01M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 371 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is REGENXBIO Inc.'s current P/E ratio?
- REGENXBIO Inc. (RGNX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is REGENXBIO Inc.'s market capitalisation?
- REGENXBIO Inc.'s market cap is $590.16M based on our latest snapshot. See how it ranks by market cap →
- What is RGNX's 52-week range?
- Over the past 52 weeks, RGNX has traded between $5.46 and $16.19. What does the 52-week range mean? →
- How volatile is REGENXBIO Inc. compared to the market?
- REGENXBIO Inc. has a beta of 0.93, meaning it has historically moved less than the broader market. What does beta measure? →
- Does REGENXBIO Inc. pay a dividend?
- REGENXBIO Inc. does not currently pay a dividend according to our latest data.
- What exchange is RGNX listed on?
- RGNX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is REGENXBIO Inc. in?
- REGENXBIO Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →